Articoli
https://www.pharmadoc.it/wp-content/uploads/2022/09/Accordi-_quadro_Liguria.png
1045
1920
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2022-09-05 12:34:472022-09-14 10:41:27La preminenza della potestà prescrittiva
https://www.pharmadoc.it/wp-content/uploads/2020/09/burden-of-proof.jpg
1296
2067
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2020-09-25 08:09:442021-09-07 15:57:26Inversione dell’onere della prova a carico di AIFA
https://www.pharmadoc.it/wp-content/uploads/2020/09/Equivalenza-Terapeutica-1.jpg
1280
1596
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2020-09-03 12:26:422022-05-05 15:48:23Nell’equivalenza terapeutica non c’è inversione dell’onere della prova
https://www.pharmadoc.it/wp-content/uploads/2020/03/140517804_xl-farmaci-off-label.jpg
1281
1920
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2020-03-20 18:53:082020-03-23 08:47:29I farmaci sperimentali e off-label
https://www.pharmadoc.it/wp-content/uploads/2018/08/Pharmakit-news-2.jpg
1507
1280
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2018-08-24 11:57:522018-12-11 17:27:05Combinazione farmaci in dose fissa e CPC: estensione della copertura brevettuale solo a determinate condizioni